Alnylam Pharmaceuticals
ALNY
#445
Rank
ยฃ39.38 B
Marketcap
ยฃ298.13
Share price
-1.37%
Change (1 day)
54.69%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company